摘要目的：探讨肺部铜绿假单胞菌感染患者抗感染治疗过程中的药学服务实践。方法：临床药师参与1 例石棉肺合并肺部铜绿假单胞菌感染患者的抗感染治疗全过程，从药物选择、给药剂量、给药间隔等方面优化抗感染治疗方案， 并密切监测药品不良反应。结果：患者病情得到有效控制，治疗29 d 后出院。结论：临床药师对患者抗感染治疗进行个体化用药监护，适当干预，协同临床医师优化治疗方案，保障了用药安全、有效、合理。
Abstract：Objective: To explore the anti-infective pharmaceutical care strategy for pseudomonas aeruginosa infection. Methods: The treatment was entirely supervised by clinical pharmacists, who were responsible for optimizing the therapeutic regimen including drug selection, drug dosage and the interval of drug delivery. Moreover, the adverse drug reactions were monitored regularly. Results: The development of disease was effectively controlled and the patient was discharged 29 d latter. Conclusion: Clinical pharmacists should provide the individualized anti-infective therapy and appropriate intervention for the patients with treatment, and make sure the use of drug in clinic is safe, effective and reasonable.
聂晓静,白荷荷,韩小年. 1例石棉肺合并肺部铜绿假单胞菌感染患者的药学监护[J]. 临床药物治疗杂志, 2017, 15(6): 69-71.
NIE Xiao-jing, BAI He-he, HAN Xiao-nian. Pharmaceutical care for a case of patient with asbestosis and pseudomonas aeruginosa infection. CLINICAL MEDICATION JOURNAL, 2017, 15(6): 69-71.
2017, Vol. 15 
